GLUCAGON-LIKE PEPTIDE-1 REGULATES MITOCHONDRIAL BIOGENESIS AND TAU PHOSPHORYLATION AGAINST ADVANCED GLYCATION END PRODUCT-INDUCED NEURONAL INSULT: STUDIES IN VIVO AND IN VITRO
GLUCAGON-LIKE PEPTIDE-1 REGULATES MITOCHONDRIAL BIOGENESIS AND TAU PHOSPHORYLATION AGAINST ADVANCED GLYCATION END PRODUCT-INDUCED NEURONAL INSULT: STUDIES IN VIVO AND IN VITRO
复制标题
胰高血糖素样肽-1 调节线粒体生物发生和 Tau 磷酸化,对抗高级糖化终产物引起的神经元损伤:体内和体外研究
DOI:
10.1016/j.neuroscience.2015.05.023
复制
发表时间:
2015-08-06
期刊:
影响因子:
3.3
通讯作者:
Gao, X. -D.
中科院分区:
文献类型:
--
作者:
An, F. -M.;Chen, S.;Gao, X. -D.
Our previous study has proved that glucagon-like peptide-1 (GLP-1), which is developed to treat type 2 diabetes, has a significant effect on neuroprotection against advanced glycation end product (AGE)-induced neuronal insult in vitro models of diabetes-related Alzheimer's disease (AD). However, the molecular mechanisms remain to be elucidated and it is not clear whether GLP-1 receptor mediates the down-regulation effects on AGE-induced AD-like changes in vivo. This study aims to explore the effect and mechanisms of GLP-1 receptor agonists (GLP-1RA) against the AGE-dependent signaling pathway both in vitro and in vivo. In this study, we demonstrated that GLP-1RA could inhibit oxidative stress and repair mitochondrial damage in addition to decreasing tau hyperphosphorylation in PC12 cells treated with AGEs. Importantly, we first observed AGEs in the circulatory system could induce tau hyperphosphorylation after we injected AGEs (1 mu g/kg bodyweight) into the mice tail vein. We found GLP-1RA could promote mitochondrial biogenesis and antioxidant system via regulating peroxisome proliferator-activated receptor gamma coactivator 1 alpha (PGC-1 alpha) signaling pathway in vivo besides down-regulating the activity of glycogen synthase kinase 3 beta (GSK-3 beta) to reverse tau hyperphosphorylation directly. Collectively, our results suggest that GLP-1RA protects neurons against AGE-induced tau hyperphosphorylation via regulating GSK-3 beta and PGC-1 alpha two cooperative signaling pathways. (C) 2015 IBRO. Published by Elsevier Ltd. All rights reserved.